Valuation: BOIRON

Market Cap 34Cr 39Cr 32Cr 29Cr 55Cr 3.72TCr 56Cr 388.29Cr 150.46Cr 1.9TCr 145.27Cr 142.11Cr 6.1TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 30Cr 33Cr 28Cr 25Cr 47Cr 3.2TCr 48Cr 334.24Cr 129.52Cr 1.64TCr 125.04Cr 122.33Cr 5.25TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.77%
1 week+0.78%
Current month-0.77%
1 month-22.82%
3 months-31.51%
6 months-28.75%
Current year-34.73%
1 week 19.45
Extreme 19.45
19.6
1 month 19.2
Extreme 19.2
26
Current year 19.2
Extreme 19.2
30.25
1 year 19.2
Extreme 19.2
31.35
3 years 19.2
Extreme 19.2
56.6
5 years 19.2
Extreme 19.2
56.6
10 years 19.2
Extreme 19.2
92.52
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%+0.78% - - 39Cr
-0.61%-3.43%+36.07%+115.04% 1,01900Cr
-1.02%-5.60%+35.72%+64.63% 62TCr
+1.11%-0.58%+12.36%+77.95% 46TCr
+0.34%-3.01%+61.79%+41.24% 36TCr
-0.95%-4.05%+20.54%+41.71% 33TCr
-1.46%-2.89%+10.57%+32.81% 27TCr
-1.35%-5.43%-6.17%+8.98% 24TCr
-1.04%-2.79%+35.30%+51.84% 22TCr
-1.87%-4.10%+28.44%+93.66% 18TCr
Average -0.76%-3.54%+26.07%+58.65% 41.08TCr
Weighted average by Cap. -0.60%-3.54%+29.07%+70.57%

Financials

2024 2025
Net sales 49Cr 55Cr 46Cr 41Cr 78Cr 5.28TCr 79Cr 550.7Cr 213.4Cr 2.7TCr 206.03Cr 201.55Cr 8.65TCr 50Cr 56Cr 47Cr 43Cr 80Cr 5.42TCr 81Cr 566Cr 219.32Cr 2.77TCr 211.75Cr 207.15Cr 8.9TCr
Net income 1.13Cr 1.28Cr 1.06Cr 96.44L 1.82Cr 122.65Cr 1.84Cr 13Cr 4.96Cr 63Cr 4.79Cr 4.69Cr 201.23Cr 3.26Cr 3.67Cr 3.05Cr 2.78Cr 5.24Cr 353.19Cr 5.29Cr 37Cr 14Cr 180.55Cr 14Cr 13Cr 579.46Cr
Net Debt -4.97Cr -5.6Cr -4.64Cr -4.23Cr -7.98Cr -538.15Cr -8.05Cr -56Cr -22Cr -275.11Cr -21Cr -21Cr -882.92Cr -4.79Cr -5.39Cr -4.47Cr -4.07Cr -7.68Cr -517.78Cr -7.75Cr -54Cr -21Cr -264.69Cr -20Cr -20Cr -849.5Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change
02/26/02 €19.45 -0.77%
01/26/01 €19.60 0.00%
30/26/30 €19.60 +0.26%
29/26/29 €19.55 +1.82%
28/26/28 €19.20 -0.52%

Annual profits - Rate of surprise